The experience gained in the investigation of 100 cases of cardiac surgery treated by use of extracorporeal circulation has shown that certain simple laboratory tests suffice to detect induced defects in the blood and to guide therapy. These tests have been devised to detect the level of circulating heparin during perfusion; the presence of residual heparin following perfusion; the existence of a qualitative or quantitative fibrinogen deficiency; excessive fibrinolysis. Any of the latter three abnormalities alone or together have caused excessive immediate post-operative blood loss. Specific therapy has not been found to be necessary unless severe bleeding occurs.
A. A. Shdrp and M. J. Eggleton TEST FOR SIGNIFICANT FIBRINOLYSIS The fibrinogen titre is carried out as above. A second row of tubes is prepared but this time with doubling dilutions of citrate plasma in a solution of E.A.C.A. (1 mg./l ml.). All tubes are clotted with thrombin and examined after 15 minutes' and 30 minutes' incubation at 370C.
Excessive lysis is considered to be present if the saline titre is two dilutions lower than the E.A.C.A. titre in 30 minutes or if all the clots in the saline titre lyse in 60 minutes.
PROTAMINE SULPHATE POLYBRENE TITRATION (MODIFICA-TION OF THE METHOD OF JAQUES, 1943) A stock solution of protamine sulphate or polybrene is made to give a concentration of 20 mg. %. Dilutions of it are made to give a range of concentrations of 20 to 1 mg. % in 1 mg. stages. Test plasma, 0-1 ml., is added to 0-1 ml. of each concentration, together with 0-1 ml. saline and 0-1 ml. human thrombin 40 u./ml. and the clotting time recorded. At the level of protamine or polybrene when heparin is neutralized the clotting time will shorten rapidly. This has been termed the 'break point' (Fig. 1) . The plasma heparin can, therefore, be expressed as milligrams % protamine or polybrene equivalent.
Blood heparin equivalent = plasma heparin equivalent 100 -haematocrit X 100 HAEMOLYSIS IN VITRO A modification of the method of Stewart and Surridge (1959) was used. Heparinized fresh blood, 5 ml., is placed in a 20 cm. length of the plastic tubing to be tested. This tubing is formed into a circle and the junction sealed with an exterior cuff. This tubing is placed on a turntable set at 200 from the horizontal and rotating at 3 to 4 r.p.m. The blood contained in the tube is allowed to flow for one hour at room temperature. The blood is then collected and the supernatant plasma examined for the amount of free haemoglobin. In one patient marked thrombocytopenia was found in association with a high packed red cell volume due to secondary polycythaemia.
Recently each patient has had a careful personal and family history taken to determine whether or not any abnormal bleeding tendency exists. This step has been found to be of increasing importance, as it is emerging that mild coagulation defects, e.g., haemophilia, Christmas disease, and von Willebrand's disease, can only be detected by specific assay systems, and are not detected by routine screening tests.
ASSESSMENT OF HEPARIN LEVEL DURING OPERATION
The heparin level is checked on three occasions by protamine sulphate or polybrene titration: 1 pump blood after priming; 2 pump-patient mixed blood at the start of perfusion; 3 during the rewarm phase approximately 30 minutes before the end of perfusion.
The patient receives 3 mg. heparin/kg. body weight and the pump blood contains 6 mg./100 ml. These amounts should be adequate for a two-hour perfusion but some variation in the heparin levels has been found. On two occasions inexplicably low levels of heparin (1 mg./100 ml.) have been found, and extra heparin has had to be given to restore the level to the target of 2 to 3 mg. %.
The heparin level should not be allowed to drop below 2 mg./100 ml. during perfusion. The average fall during perfusion has been 1 to 1-5 mg./100 ml. per two-hour perfusion.
POLYBRENE OR PROTAMINE NEUTRALIZATION OF HEPAR1N Either polybrene or protamine sulphate has been given at the end of perfusion to neutralize the total calculated dose of heparin that the patient received by injection and from the pump blood. This calculated level has been approximately 4 mg. %, allowing for a total blood volume of 80 ml./kg. body weight. When the antidote was given to neutralize the amount of titratable heparin left in the blood at the end of perfusion, it was found to be inadequate and detectable residual heparin remained.
RESIDUAL HEPARIN It has been found to be of prime importance to ensure that at the end of perfusion the last trace of heparin is neutralized, as this has caused excessive and immediate severe post-operative blood loss.
The thrombin clotting time of plasma prepared from blood collected after the theoretical neutralizing polybrene dose has been given hasproveda simple and effective method of detecting residual heparin.
If it was found to be more than five seconds longer than the pre-perfusion thrombin clotting time, then the test was repeated with added polybrene or protamine (1 mg./100 ml.). If this latter step shortened the clotting time, residual heparin was assumed to be present and a further dose of the antidote given. If polybrene or protamine had no effect, then the prolongation was considered to be due to fibrinfibrinogen breakdown products in excess amounts (Latallo, Fletcher, Alkjaersig, and Sherry, 1962 was given, in eight because of severe bleeding and in four because of a severe deficiency of fibrinogen and excessive lysis. Seven cases received doses of 5 g. fibrinogen to raise the fibrinogen levels. Three cases were also given epsilon-amino-caproic acid (E.A.C.A.) because of failure to respond to fibrinogen; two patients received E.A.C.A. alone (Table III) . In eight cases excessive bleeding was attributed to defibrination with excessive lysis, and in seven therapy was immediately effective (Table III) . HAEMOLYSIS This in our experience has not been a problem, although in one case a calculated 350 ml. of blood lysed in the early stages of perfusion. However, perfusion and surgery proceeded normally and renal function was not impaired. Various types of plastic tubing are offered by several manufacturers for the extracorporeal circulation, and it is difficult to determine which is suitable. Using a modification of the method of Stewart and Surridge (1959) , it has been possible to assess the haemolysis factor of various plastics and thus to select the best available.
PLATELETS In every case the platelet count dropped during perfusion (Fig. 2) , and this tendency was increased by the use of hypothermia. Immediately after perfusion the platelet count has risen, only to fall again in the next 12 hours to a level similar to that reached during perfusion. It has returned to normal levels one to 10 days after operation. (Table IV) . Although the thrombocytopenia occurring during perfusion has not improved, the post-operative return to normal has been quicker (Table IV) . Rheomacrodex has been criticized for increasing the operative blood loss (Breckenridge and Walker, 1963) but in the present series, while the operative and immediate excessive post-operative loss has not been increased and in fact has decreased, the amount of blood draining from the chest cavity in the first six hours after operation has increased. shortened, then the presence of fibrinogen-fibrin degradation products, which appear whenever defibrination or fibrinolysis occur, should be suspected. This finding agrees with the observations of Rothnie and Kinmonth (1960) . The neutralization of heparin with protamine or polybrene in amounts equivalent to the titratable heparin at the end of perfusion has been shown to be unsuccessful, and the dose of antidote has had to be equivalent to the total calculated and not titrated heparin in the patient's blood volume at the start of perfusion. Why this should be so is difficult to explain, but it must be assumed that some heparin quickly escapes into the extravascular fluid where it remains until the blood heparin is neutralized. The return of this extravascular heparin must take place immediately this is done. Delayed heparin rebound has never been detected. Defibrination or excessive fibrinolysis or both have also been associated with severe haemorrhage in the immediate post-operative period. Simple tests can detect and quantitate these defects quickly, and the haematologist can warn the surgeon of impending trouble, or in consultation advise as to the appropriate therapy and assess its results. Fibrinolysis could be detected in the majority of cases and is inevitable in blood perfusing damaged tissues, in which a certain amount of fibrinogen is being precipitated or converted to fibrin. This activation of fibrinolysis is probably nature's way of protecting the body from the effects of intravascular fibrin formation, and its presence should be considered as beneficial to the host. However, occasionally excessive and violent lysis has developed which was so severe that it was likely to harm the patient. The test described for detecting this excessive lysis is semi-quantitative and appears to provide a rough but effective guide to the presence of severe fibrinolysis. Tests, such as Euglobulin lysis, are too sensitive to be a guide to the presence of dangerous lysis. However, even if violent lysis is found it should not be neutralized unless it is obvious that it is causing excessive and dangerous blood loss. If lysis is left untreated it is rare to find any detectable activity one hour after perfusion. Patients whose blood has shown severe defibrination or lysis and who have not bled, have been treated, but it is now our opinion that there is no need to treat such laboratory defects, however severe, if no bleeding develops. This view is supported by observations by Reid, Chan, and Thean (1963) The increase in the amount of post-operative drainage in those patients receiving rheomacrodex has tended to negate the saving of blood initially on priming the pump and it is difficult to assess whether this is a good or bad feature. However, it has caused no harm to any patient, and in fact is attributed to the better perfusion of damaged tissues by the blood. This theory is at least as possible as the plasma dilution theory of Breckenridge et al. (1963) .
In the majority of cases polybrene has been used to neutralize heparin. No complications have occurred with its use and it has proved to be more efficient weight for weight than protamine sulphate and a more certain antidote. However, following reports that it may produce renal damage (Haller, Ransdell, Stowens, and Rubel, 1962) it has been replaced by protamine sulphate. Effective neutralization of heparin by either of these drugs has effectively and quickly stopped heparin-induced bleeding. Profound hypothermia has not been shown to damage the blood by itself and in fact allows for longer perfusion times. Prolonged perfusion beyond the usual period of one and a half to two hours has raised the incidence of complications and postoperative bleeding has occurred more often as a result. It also appears to prejudice the ability of the heart to resume its normal rhythm and output. Severe tissue anoxia due to bad perfusion or a failing heart post-operatively has on one occasion provoked severe bleeding which could not be explained by the demonstration of any defect in the blood. Low heparin levels during perfusion must be avoided, as the level of heparin may suddenly drop as perfusion proceeds, and the blood in the pump may clot. If this were to happen, the resultant explosive coagulation would not be confined to the pump, as it would be immediately transmitted to the patient's circulation which is in continuity. This continuity must be remembered when transfusing blood into the patient during perfusion. Any bank blood must be heparinized when transfused into the pump or patient during perfusion, otherwise a sudden drop of the circulating heparin level will result. Fantl and Ward (1960) suggested that the lowest safe level of heparin that would prevent clotting was 1-2 mg. % and, to neutralize the thromboplastic activity of the blood, 2 mg. % was necessary. Therefore 2 to 3 mg. % should be the target level for perfusion. High levels of heparin, i.e., above 5 mg. %, do not appear to increase the blood loss during perfusion.
In the rewarm phase, the temperature of the water in the heat exchanger must never be allowed to rise above 40°C., as higher temperatures may denature circulating proteins and, if above 50°C., may precipitate fibrinogen.
Although deficiencies of coagulation factors other than those discussed do develop during perfusion it is difficult to assess the degree and significance of the deficiency in relation to the complex abnormalities existing in the blood after perfusion. All that can be said is that they do not appear to cause excessive and dangerous bleeding and can, in our experience, be ignored.
